Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Christophe Louandre"'
Autor:
Claire Lailler, Michele Lamuraglia, Floriane Racine, Christophe Louandre, Corinne Godin, Bruno Chauffert, Antoine Galmiche, Zuzana Saidak
Publikováno v:
Translational Oncology, Vol 14, Iss 8, Pp 101110- (2021)
Objectives: The immune checkpoint molecule PD-L1 (CD274) is a crucial regulator of the tumor immune response. Its expression has been reported in the therapeutic context in Head and Neck Squamous Cell Carcinoma (HNSCC), but it remains unclear how the
Externí odkaz:
https://doaj.org/article/c882ce83fab946c98b707b15acba5884
Autor:
Denis Chatelain, Jean-Claude Mazière, Gilles Duverlie, Jean-Claude Barbare, Jean-Paul Joly, Jean-Marc Regimbeau, Corinne Godin, Nathalie Trouillet, Véronique Descamps, Eric Nguyen-Khac, Charles Sabbagh, Christophe Louandre, Catherine François, Zakaria Ezzoukhry, Antoine Galmiche
Proteins of the BCL2 family are key regulators of apoptosis. Their expression levels are frequently altered in cancers, enabling tumor cells to survive. To gain insight into the pathogenesis of hepatocellular carcinoma (HCC), we performed a comprehen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c92745c33eeea235e392bb7d3c57ce
https://doi.org/10.1158/1541-7786.c.6542223.v1
https://doi.org/10.1158/1541-7786.c.6542223.v1
Autor:
Denis Chatelain, Jean-Claude Mazière, Gilles Duverlie, Jean-Claude Barbare, Jean-Paul Joly, Jean-Marc Regimbeau, Corinne Godin, Nathalie Trouillet, Véronique Descamps, Eric Nguyen-Khac, Charles Sabbagh, Christophe Louandre, Catherine François, Zakaria Ezzoukhry, Antoine Galmiche
Supplementary Figures S1-S6; Supplementary Materials and Methods; Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190905a9d5cbeb885d8071c221463250
https://doi.org/10.1158/1541-7786.22519005
https://doi.org/10.1158/1541-7786.22519005
Autor:
Floriane Racine, Christophe Louandre, Corinne Godin, Baptiste Chatelain, Stefan Prekovic, Wilbert Zwart, Antoine Galmiche, Zuzana Saidak
Publikováno v:
Cancers, 15(5):1531. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Volume 15
Issue 5
Pages: 1531
Cancers
Volume 15
Issue 5
Pages: 1531
Background: The coagulome, defined as the repertoire of genes that locally regulate coagulation and fibrinolysis, is a key determinant of vascular thromboembolic complications of cancer. In addition to vascular complications, the coagulome may also r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d4944bfa4202ae92b78c70c4b6cae67
https://research.tue.nl/nl/publications/f4cf613e-852e-42c7-bc73-0f2d11fd7566
https://research.tue.nl/nl/publications/f4cf613e-852e-42c7-bc73-0f2d11fd7566
Autor:
Michele Lamuraglia, Floriane Racine, Claire Lailler, Antoine Galmiche, Zuzana Saidak, Bruno Chauffert, Corinne Godin, Christophe Louandre
Publikováno v:
Translational Oncology
Translational Oncology, Elsevier, 2021, 14 (8), pp.101110. ⟨10.1016/j.tranon.2021.101110⟩
Translational Oncology, 2021, 14 (8), pp.101110. ⟨10.1016/j.tranon.2021.101110⟩
Translational Oncology, Vol 14, Iss 8, Pp 101110-(2021)
Translational Oncology, Elsevier, 2021, 14 (8), pp.101110. ⟨10.1016/j.tranon.2021.101110⟩
Translational Oncology, 2021, 14 (8), pp.101110. ⟨10.1016/j.tranon.2021.101110⟩
Translational Oncology, Vol 14, Iss 8, Pp 101110-(2021)
Highlights • PD-L1 is an important immune checkpoint molecule expressed by HNSCC. • 5-FU induces PD-L1 expression in HNSCC cells. • PD-L1 upregulation is DNA damage Response- and JAK-dependent. • 5-FU potentiates the effect of the inflammator
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db9adfddec84ee15f59ece028939f56d
https://hal.sorbonne-universite.fr/hal-03219798/file/1-s2.0-S1936523321001029-main.pdf
https://hal.sorbonne-universite.fr/hal-03219798/file/1-s2.0-S1936523321001029-main.pdf
Autor:
Antoine Galmiche, Christophe Louandre, Yves-Edouard Herpe, Chloé Sauzay, Amandine Dernoncourt, Cathy Gomila, Pierre Duhaut, Jean Schmidt, V. Salle, Zuzana Saidak
Publikováno v:
Anticancer Research
Anticancer Research, 2021, 41 (9), pp.4305-4312. ⟨10.21873/anticanres.15235⟩
Anticancer Research, 2021, 41 (9), pp.4305-4312. ⟨10.21873/anticanres.15235⟩
International audience; Background/Aim: Multiple myeloma (MM) is characterized by high production of immunoglobulins resulting in a constant source of endoplasmic reticulum (ER)-stress. Mesencephalic astrocyte-derived neurotrophic factor (MANF) was i
Autor:
Antoine Galmiche, Véronique Descamps, Gabriel Choukroun, Rémy Nyga, Sandra Bodeau, Catherine François, Christophe Louandre, Corinne Godin, Chloé Sauzay
Publikováno v:
Anticancer Research
Anticancer Research, 2017, 37 (3), pp.1049-1057. ⟨10.21873/anticanres.11416⟩
Anticancer Research, 2017, 37 (3), pp.1049-1057. ⟨10.21873/anticanres.11416⟩
International audience; Background/Aim: Organ transplant patients treated with the immunosuppressive drug cyclosporine A often present malignant kidney tumors. Cyclosporine A can promote oncogenesis in a cell-intrinsic manner by increasing the produc
Autor:
Antoine Galmiche, Christophe Louandre, Bruno Chauffert, Jean-Marc Constans, Mony Chenda Morisse, Zuzana Saidak, Claire Lailler, Corinne Godin, Thomas Lhossein, Marine Lottin
Publikováno v:
Bioscience Reports
The tumor microenvironment is an important determinant of glioblastoma (GBM) progression and response to treatment. How oncogenic signaling in GBM cells modulates the composition of the tumor microenvironment and its activation is unclear. We aimed t
Autor:
Irène Ceballos-Picot, Zuzana Saidak, Denis Chatelain, Sara Guedda, Samy Dahmani, Bruno Chauffert, Chloé Sauzay, Christophe Louandre, Antoine Galmiche
Publikováno v:
Bioscience Reports. 38
Uric acid (UA) is the end product of the catabolism of purines, and its serum levels are commonly increased in cancer patients. We aimed to explore the transcriptional regulation of tumour uricogenesis in human tumours, and relate uricogenesis with t
Autor:
Catherine François, Sandra Bodeau, Jean Claude Barbare, Zuzana Saidak, Antoine Galmiche, Romain Coriat, Christophe Louandre, Corinne Godin, Chloé Sauzay
Publikováno v:
Oncology Reports
Oncology Reports, 2019, 41 (3), pp.2041-2050. ⟨10.3892/or.2018.6922⟩
Oncology Reports, 2019, 41 (3), pp.2041-2050. ⟨10.3892/or.2018.6922⟩
International audience; Sorafenib is the standard of care for the treatment of advanced hepatocellular carcinoma (HCC). However, identifying secreted biomarkers that predict sorafenib efficacy in all HCC patients remains challenging. It was recently